The latest health news includes Illumina's launch of affordable gene sequencers, Pfizer's promising cancer drug trials, CVS ...
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
Health-care companies rose as traders hedged their bets on the outlook for growth in the sector. Bayer shares fell sharply after Washington state's top court granted a petition for review in a case ...
Another jury in the same courthouse handed a verdict last month to a separate Zantac manufacturer, GlaxoSmithKline. On May 23, an Illinois jury sided with both drug manufacturers in the first ...
An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but won’t be the last. A juror’s note—"I must leave. This has not been resolved" ...
A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow ...
In Delaware, the top court is rehearing the trial court’s evidentiary ruling admitting plaintiffs’ experts’ testimony in the Zantac cases. The Third Circuit has ruled that Monsanto (Bayer) may avail ...
By Brendan Pierson (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...
A Chicago jury failed to reach a verdict in the latest Zantac cancer trial involving Boehringer Ingelheim. Plaintiff Ronald Kimbrow claims the heartburn drug caused his prostate cancer. This marks the ...
Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a beautiful day as well, despite forecasts suggesting a cloud or two will later hover about. Right now, the ...
Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since it was approved in 1983, and have been named in tens of thousands of lawsuits over the alleged cancer ...